Poslední aktualizace :
08/05/2024
Kraujagysles plečiantis vaistas   Phentolamine mesylate  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija Pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Ora Verse Jungtinės Amerikos Valstijos, Kanada
Phentolamine mesylate Prancūzija
Regitine Olandija
Bibliografija   Įpurškimas   Bibliografija : Phentolamine mesylate  
Tipas Leidinys
456 Žurnalas Tu YH, Allen LV, Wang DP.
Stability of papaverine hydrochloride and phentolamine mesylate in injectable mixtures.
Am J Hosp Pharm 1987 ; 44: 2524-2527.
1036 Žurnalas Hasegawa GR, Eder JF.
Visual compatibility of amiodarone hydrochloride injection with other injectable drugs.
Am J Hosp Pharm 1984 ; 41: 1379-1380.
1041 Žurnalas Hasegawa GR, Eder JF.
Visual compatibility of dobutamine hydrochloride with other injectable drugs.
Am J Hosp Pharm 1984 ; 41: 949-951.
1057 Žurnalas Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1899 Žurnalas Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2150 Žurnalas Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
3172 Žurnalas Xu F, Xu G, LSu L, Feng E.
Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion.
J Clin Pharm Ther 2011 ; 36, 1: 99-102.
4389 Žurnalas Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213

  Mentions Légales